SCHEMBL22377490

SCHEMBL22377490

N#Cc1ccc(-n2c3ccccc3c3ccccc32)cc1-c1ccccc1-c1cccc(C#N)c1-n1c2ccccc2c2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ALDH1A1 P00352 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
AR P10275 4/20 0.35
IMPDH2 P12268 1/20 0.34
NR3C1 P04150 1/20 0.33
MAPT P10636 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
USP8 P40818 1/20 0.32
USP7 Q93009 1/20 0.32
ESR2 Q92731 1/20 0.32
MEN1 O00255 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19755253 0.99 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL22378854 0.92 KDM1A (0.33) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL22379062 0.92 KDM1A (0.33) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL22377586 0.90 ESR2 (0.39) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL22378405 0.90 KDM4E (0.37) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL22153512 0.89 KDM4E (0.39) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL22378445 0.89 ALDH1A1 (0.39) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL22379302 0.89 KDM4E (0.37) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL19755311 0.88 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL22378707 0.88 KDM4E (0.36) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-10-24 US disclosed
US-20200274074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200274074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CYP1A1, CRY2 KDM4E 3290/4885ATM 3429/4885L3MBTL1 1164/4885
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same CRY1, CYP1A1, CRY2 KDM4E 3290/4885ATM 3429/4885L3MBTL1 1164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.